Navigation Links
Vet-Stem, Inc. Founder and CEO, Dr. Robert Harman, to Speak at North American Veterinary Regenerative Medicine Association Conference
Date:10/30/2013

Poway, California (PRWEB) October 30, 2013

Robert Harman, DVM, Founder and CEO of Regenerative Veterinary Medicine company Vet-Stem, Inc. is scheduled to speak at the North American Veterinary Regenerative Medicine Association (NAVRMA) Conference in Atlanta, Georgia November 10-13, 2013. Dr. Harman is scheduled to speak on the third day of the conference, Tuesday, November 12, 2013 in the Industry Session beginning at 1:00pm.

In his presentation titled “One Medicine and Collaboration for Rapid Development of Cell Therapy” Dr. Harman will show a model and examples of collaborations between commercial, academic, human and veterinary groups to the betterment of all medical progress. He will illustrate how veterinary stem cell medicines have impacted the clinical progress of human stem cell medicines development.

He pulls from his biotechnology and veterinary experience to help Vet-Stem perfect the clinical application of stem cell therapy for various types of injuries, illnesses, and other healing-promoting applications. Vet-Stem is leading in the development for regenerative medicine in the veterinary field, with over 10,000 animals treated in the last 10 years.

Vet-Stem first pioneered stem cell therapy for use in horses for tendon injuries, as an alternative to other choices such as euthanasia. Just two years after the first horse was treated, Vet-Stem treated the first cat and dog.

In 2007 the first peer reviewed, randomized, double-blinded, placebo controlled, multi-center study was published proving intra-articular injection of adipose derived stem cells in the hip joint of a dog decreased patient discomfort and increased patient functional ability. That same year Vet-Stem brought to market the Genesis Platelet Rich Plasma concentration system, as well as the first formal small animal stem cell credentialing course.

This year NAVRMA is taking place inside the Tissue Engineering and Regenerative Medicine International Society (TERMIS) Americas Annual Conference and Exposition. NAVRMA promotes the acquisition and distribution of knowledge regarding the emerging fields of regenerative medicine and stem cell therapy.

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11278537.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Former COO and CSO of IDEXX Laboratories, Inc. Joins Board of Directors for Vet-Stem, Inc.
2. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Presents at Prestigious Stem Cell Conference at Case Western Reserve University
3. Vet-Stem, Inc. Founder, Robert Harman, DVM, Invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner
4. The Veterinary Cooperative (TVC) and Vet-Stem, Inc. Announce an Exclusive Partnership to Offer Regenerative Medicine and Stem Cell Therapy to Over 300 Member Hospitals
5. Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference
6. The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to Their Patients
7. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
8. Vet-Stem, Inc. Founder and CEO Presents at TargetMeeting’s 3rd World Drug Discovery Online Conference
9. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
10. Radiotherapy Clinics of Georgias Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award
11. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2018)... ... August 01, 2018 , ... ... announces research results on the significant impact of a proprietary biofield energy ... , The preclinical research assessed biomarkers for systemic and organ-specific inflammation, as ...
(Date:7/27/2018)... ... July 27, 2018 , ... ... and representatives of the Biotechnology Innovation Organization (BIO) met with U.S. Environmental ... “Proposal for a Toxic Substances Control Act (TSCA) Inventory Representation and Equivalency ...
(Date:7/25/2018)... Calif. (PRWEB) , ... July 25, 2018 , ... ... in vivo research utilizing its state-of-the-art Digital Vivarium™ and Vium Cloud approach to ... Ph.D., to Chief Scientific Officer. Additionally, the company announced the appointment of Jeff ...
(Date:7/24/2018)... , ... July 23, 2018 , ... ... a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and immune ... function response assessed in the preclinical research were significantly reduced. Results are as ...
Breaking Biology Technology:
(Date:8/9/2018)... ... 2018 , ... Plum Alley Investments, an innovative platform providing ... has invested in a sought-after $23 million Series A round for Mammoth Biosciences ... Biosciences , The biotech company is bringing to market the latest CRISPR innovations ...
(Date:8/7/2018)... ... August 07, 2018 , ... ... development, announces a new publication titled, “Synthetic Molecules for Disruption of the ... paper prominently features use of Agile R100, described as a “ field-effect transistor ...
(Date:8/1/2018)... ... August 01, 2018 , ... Dr. Asher Kimchi, Founder and Chairman of the ... 2018 IAC Awards at the 23rd World Congress on Heart Disease held in Boston, ... to receive the Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Chairman Dr. ...
Breaking Biology News(10 mins):